Nateglinide-Tablettenzubereitungen

European patent · EP1586314 · Deleted

Register entry

Publication number
EP1586314
Application number
EP05014497
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 14, 1997
Published
Oct 19, 2005
Granted
Mar 30, 2011
Deleted
Nov 13, 2017
Reason
Maximum term reached
IPC classes
A61K 31/195 (2006.01)
A61K 9/20 (2006.01)
A61K 47/38 (2006.01)
Priority
JP 31854196 15.11.1996
Divided from
EP97912459
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 20, 2017

    Maximum term reached

    Published in Swissreg on 20.11.2017

  2. Aug 19, 2016

    Transferred

    Owner
    Ajinomoto Co., Inc., 15-1, Kyobashi 1-chome,, Chuo-ku, Tokyo 104-8315, Japan → EA Pharma Co., Ltd., 2-1-1, Irifune, Chuo-ku, Tokyo 104-0042, Japan

    Published in Swissreg on 19.08.2016

  3. May 5, 2011

    Agent entered

    Representative
    MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

    Published in Swissreg on 05.05.2011

  4. Mar 30, 2011

    Granted

    Published in Swissreg on 30.03.2011

Parties

Holder

EA Pharma Co., Ltd.

2-1-1, Irifune Chuo-ku, Tokyo 104-0042, JP

Agent

MICHELI & CIE SA

122, Rue de Genève Case postale 61, 1226 Thônex

Inventor

Yabuki, Akira

Kanagawa-Ken 210, JP

Kaida, Masato

Kanagawa-Ken 210, JP

Ando, Takahiko

Kanagawa-Ken 210, JP

Ninomiya, Nobutaka

Kanagawa-Ken 210, JP

Ozaki, Masanao

Kanagawa-Ken 210, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.